Effectiveness and safety of 110 or 150 mg dabigatran versus vitamin K antagonists in non ‐valvular atrial fibrillation.
ConclusionIn real life D110 and D150 were at least as effective and safer than VKA.
Source: British Journal of Clinical Pharmacology - Category: Drugs & Pharmacology Authors: Patrick Blin,
Caroline Dureau ‐Pournin,
Yves Cottin,
Jacques Bénichou,
Patrick Mismetti,
Abdelilah Abouelfath,
Regis Lassalle,
Cécile Droz,
Nicholas Moore Tags: ORIGINAL ARTICLE Source Type: research
More News: Atrial Fibrillation | Bleeding | Drugs & Pharmacology | Pradaxa | Stroke | Study | UK Health | Vitamin K | Vitamins